We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 1,166,433 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
TIDMSUN
RNS Number : 5194A
Surgical Innovations Group PLC
27 March 2017
Surgical Innovations Group plc
(the "Company")
Issue of Shares
Surgical Innovations Group plc (AIM: SUN) has issued and allotted a total of 820,845 ordinary shares of 1p each ("Shares") at a price of 3.575p per share to Nigel Rogers, Executive Chairman, and Michael McMahon, Non-Executive Director in lieu of remuneration for the first quarter of 2017 and Melanie Ross, Chief Operating Officer representing 50% of her bonus for the year ended 31 December 2016 under the terms of her engagement.
Details of the Shares issued and the resulting holdings of each of the directors are as follows:
Director Shares Resulting Percentage issued holding of enlarged share capital Nigel Rogers 102,266 3,573,583 0.67% Michael McMahon 83,916 18,255,312 3.42% Melanie Ross 634,663 1,240,347 0.23%
The issue price was set at the closing price on the date of the Company's payroll in March.
Application will be made for 820,845 Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 30 March 2017.
Following Admission, the total number of ordinary shares in issue will be 534,228,601 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of calculating their holding in the Company under the Disclosure Guidance and Transparency Rules.
For further information please contact:
Surgical Innovations Group www.sigroupplc.com plc Nigel Rogers, Executive Tel: 0113 230 7597 Chairman Melanie Ross, COO & Finance Director WH Ireland Limited (NOMAD Tel: 0113 394 6600 & Broker) Tim Feather/Ed Kennedy Walbrook PR (Financial PR Tel: 020 7933 8780 or & Investor Relations) si@walbrookpr.com Paul McManus Mob: 07980 541 893
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEQZLFLDXFBBBV
(END) Dow Jones Newswires
March 27, 2017 02:00 ET (06:00 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions